Previous studies have found that the intracerebral administration of human ApoE2 into ABCA1fl/fl stroke mice significantly elevated the brain level of ApoE and HDL and increased gray/white matter density and neurogenesis, as well as improved neurological functional outcome after stroke [31]. This evidence concerns the gene APOE and Stroke.